InvestorsHub Logo
icon url

Rubyred77

04/12/21 1:32 PM

#306664 RE: raja48185 #306663

Nope, they sure don’t. Most have still never heard of Anavex Life Sciences.

We are headed to the End Game. Out of the thousands of possibilities, Dr. Missling decided to go the route he has.

I’ll take an Anavex Delay over a BIIB FIB any day.

Within the next 365 days, at minimum, we shall see if we have a blockbuster, or dud.




icon url

mrplmer

04/12/21 2:01 PM

#306669 RE: raja48185 #306663

100% accurate. So you aren't investing in a stock or science,you are investing in a single man. Not GOOD. What is the succession plan? What happens if he buys the farm?
icon url

TempePhil

04/12/21 3:03 PM

#306681 RE: raja48185 #306663

Price drop because...

PR said:

The respective ongoing placebo-controlled Phase 2 and Phase 2/3 ANAVEX®2-73 clinical studies in adult (AVATAR) and pediatric (EXCELLENCE) patients with Rett syndrome are expected to be completed by mid 2021 and 2H 2021, respectively.


Avatar was supposed to be done 2 months ago, but is pushed out to midyear by the PR, and it HAS 5 SITES AND ONLY 30 PATIENTS. BTW, originally, they guessed Avatar would be done almost a year ago. Powers of prognostication pretty poor.

The Excellence study is supposed to complete in next 2 months(per clinicaltrials.gov), yeah right. BUT IT HAS ONLY 2 SITES OPEN AND NEEDS 69 PATIENTS! The PR now says it will be done 2nd half of this year. Huh, how will even that delay work with two sites open, dont hold your breath.

Why are we sitting on all this cash and not opening sites for Excellence!

All supposed times are from clinicaltrials.gov.

And we give out huge options rewards????

Raja, just fleshing out your delay comment.